Summary
Signal counts
Assets tracked: 3
Watchlist assets: 2
Registry stop assets: 0
Sponsor overview
SWOG Cancer Research Network
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT05633615 | https://clinicaltrials.gov/study/NCT06773936 | https://clinicaltrials.gov/study/NCT03851445
Assets
Linked programs
- Axicabtagene Ciloleucel: Operational Burden Signal (2/5)
- Induction Phase: Low Signal (1/5)
- Screening Platform: Operational Burden Signal (2/5)